期刊文献+

NFYA在肝细胞癌中的表达、预后及免疫特征的综合分析 被引量:1

Comprehensive analysis of the expression,prognosis,and immune profiles of NFYA in hepatocellular carcinoma
下载PDF
导出
摘要 目的:基于公共数据库、体外细胞系和肿瘤组织分析核转录因子Y亚基A(nuclear transcription factor Y subunit A, NFYA)在肝细胞癌(hepatocellular carcinoma, HCC)中的表达和临床意义。方法:TCGA数据库获取HCC患者临床数据和转录组数据并进行分析,qRT-PCR和免疫组化染色法验证NFYA在HCC细胞系和患者组织中的表达。单因素和多因素Cox回归分析、Kaplan-Meier分析、GO和KEGG分析等方法分析NFYA表达水平与HCC患者临床病理特征、预后、潜在致病机制以及免疫细胞浸润等的相关性。结果:公共数据库分析显示NFYA mRNA在HCC组织中较正常肝组织表达显著增高,并且该现象在HCC细胞系中得到了验证;在研究者队列HCC组织中,NFYA蛋白表达量也显著高表达。NFYA mRNA表达水平与HCC患者组织学分级、T分期、病理学分期正相关;NFYA高表达的HCC患者预后更为不良;HCC中与NFYA相关的基因主要富集于核裂解、细胞周期等生物过程;肿瘤微环境分析提示NFYA高表达与较低的免疫细胞浸润及基质细胞浸润相关,且NFYA表达与多种免疫检查点基因表达呈正相关。结论:HCC患者高表达NFYA与预后不良相关,可作为HCC患者潜在的预后标志物,且可能通过影响细胞周期和免疫细胞浸润调控HCC发生发展。 Objective:To analyze the expression and clinical significance of nuclear transcription factor Y subunit A(NFYA)in hepatocellular carcinoma(HCC)based on public databases and studies in vitro cell lines and tumor tissues.Methods:Transcriptome and clinical data of HCC patients were obtained and analyzed from the TCGA database.The expression of NFYA in HCC cell lines and patient tissues was validated through qRT-PCR and immunohistochemical staining.The correlation between NFYA expression levels and clinical-pathological features, prognosis, potential pathogenic mechanisms and immune cell infiltrationwas analyzed using univariate and multifactorial Cox regression analysis, Kaplan-Meier analysis, GO and KEGG analysis. Re⁃sults: NFYA mRNA expression was significantly increased in HCC tissues compared to normal liver tissues, and this phenomenonwas also confirmed in HCC cell lines. In the study cohort of HCC tissues, NFYA protein expression was significantly upregulated.NFYA mRNA expression level was correlated with tumor histological grade, T stage, and pathological stage. HCC patientswith high NFYA expression had a worse prognosis. NFYA-related genes in HCC were mainly enriched in biological processessuch as nuclear cleavage and cell cycle.The analysis of the tumor microenvironment suggested that high NFYA expression wasassociated with lower immune cell infiltration and stromal cell infiltration, and that NFYA expression was positively correlatedwith the expression of multiple immune checkpoint genes. Conclusion: NFYA is overexpressed and associated with poor prognosisin HCC patients and may serve as a potential prognostic marker. This activity of NFYA in HCC might be related to its influenceon cell cycle and immune cell infiltration.
作者 张文婷 季文斌 吕振宇 程倩倩 于金慧 杨燕 ZHANG Wenting;JI Wenbin;LV Zhenyu;CHENG Qianqian;YU Jinhui;YANG Yan(Department of Medical Oncology,The First Affiliated Hospital of Bengbu Medical College,Bengbu 233004,China)
出处 《海南医学院学报》 CAS 北大核心 2024年第5期359-366,共8页 Journal of Hainan Medical University
基金 安徽省高校自然科学研究重大项目(2023AH040291) 安徽省卫健委卫生健康科研重点项目(AHWJ2022a010) 安徽省高校优秀青年人才支持计划项目(gxyq2022042) 蚌埠医学院研究生科研创新计划项目(Byycx23140)。
关键词 肝细胞癌 NFYA 预后 细胞周期 免疫浸润 Hepatocellular carcinoma NFYA Prognosis Cell cycle Immune infiltration
  • 相关文献

参考文献3

二级参考文献19

  • 1张艳,陈彬,陈敏,李渝萍,陈健,娄桂予,周度金.人PNRC基因启动子的初步鉴定[J].中国生物化学与分子生物学报,2007,23(4):278-284. 被引量:3
  • 2Zhou D, Quach K M, Yang C, et al. PNRC: a praline-rich nuclear receptor coregulatory protein that modulates transcriptional activation of multiple nuclear receptors including orphan receptors SF1 (steroidogenic factor 1) and ERRalpha1 (estrogen related receptor alpha-1) [J]. Mol Endocrinol, 2000, 14 (7) : 986-998
  • 3Xu J, Li Q. Review of the in vivo functions of the p160 steroid receptor coactivator family [ J ]. Mol Endocrinol, 2003, 17 ( 9 ) : 1681-1692
  • 4Zhou D, Ye J J, Li Y, et al. The molecular basis of the interaction between the proline-rich SH3-binding motif of PNRC and estrogen receptor alpha[J]. Nucleic Acids Res,2006, 34(20) :5974-5986
  • 5Zhou D, Chen B, Ye J J, et al. A novel crosstalk mechanism between nuclear receptor-mediated and growth factor/Ras-mediated pathways through PNRC-Grb2 interaction[J]. Oncogene, 2004, 23 (31 ) : 5394-5404
  • 6Kanai Y, Ushijima S, Saito Y, et al. MRNA expression of genes altered by 5-azacytidine treatment in cancer cell lines is associated with clinicopathological parameters of human cancers[ J]. J Cancer Res Clin Oncol, 2001,127 (12): 697-706
  • 7Zhou D, Clarke P, Wang J, et al. Identification of a promoter that controls aromatase expression in human breast cancer and adipose stromal cells[J]. J Biol Chem, 1996,271(25) : 15194-15202
  • 8Daly R J, Gu H, Parmar J, et al. The docking protein Gab2 is overexpressed and estrogen regulated in human breast cancer [ J ]. Oncogene, 2002, 21(33): 5175-5181
  • 9庞雄昊,陈敏山,贾卫华,周昕熙.负载人AFP肽段的树突细胞在体内外对小鼠肝癌的抑制作用[J].癌症,2008,27(12):1233-1238. 被引量:1
  • 10陈丽华,沈维高,芦丽莉,陈丽松,刘艳波.减毒沙门菌携带survivin特异性siRNA对肝细胞癌的生长抑制作用及其相关机制[J].吉林大学学报(医学版),2011,37(5):855-860. 被引量:2

共引文献1538

同被引文献15

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部